Ambalal Sarabhai Enterprises Share Price Today | Stock Price & Ambalal Sarabhai Enterprises Share Screener
As of August 19, 2026, the live Ambalal Sarabhai Enterprises share price (NSE: AMBALALSA) is ₹46.32 on NSE and ₹37.80 on BSE, down 2.71% from the previous close, with shares trading between ₹45.15 and ₹47.94 in today's trading session, and a 52-week range of ₹30.89–₹48.27. Check Ambalal Sarabhai Enterprises 52-week for the annual price range and momentum. Use the Ambalal Sarabhai Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Ambalal Sarabhai Enterprises opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹46 and net income of ₹4, with EBITDA of ₹7, an operating margin of 10.0% and a profit margin of 8.7%.
Ambalal Sarabhai Enterprises Share Price Chart
Track the current stock price of Ambalal Sarabhai Enterprises with an interactive chart. Analyse AMBALALSA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Ambalal Sarabhai Enterprises stock quote in one place.
The quote of ₹46.32 sits between the 52-week low of ₹30.89 and the 52-week high of ₹48.27, and the latest session moved -2.71% from the previous close.
Ambalal Sarabhai Enterprises Company Profile - Fundamental Screener
Screen Ambalal Sarabhai Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMBALALSA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE432A01017.
Company Details
Classification
Identifiers and Leadership
Ambalal Sarabhai Enterprises Balance Sheet Screener
Screen AMBALALSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹281, up from ₹272 in 2025.
Latest statistics put total assets at ₹281 and shareholder funds at ₹158, with a leverage ratio of 0.36.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 281 | 272 | 250 | 246 | 231 | 210 | 186 | 215 | 200 | 164 |
| Current Assets | 125 | 119 | 119 | 111 | 120 | 121 | 104 | 116 | 114 | 73 |
| Fixed Assets | 89 | 88 | 88 | 85 | 58 | 57 | 58 | 58 | 59 | 72 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 24 | 11 | 11 | 12 | 5 | 8 | 8 | 13 | 18 | 14 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 158 | 140 | 136 | 131 | 120 | 74 | 45 | 31 | 27 | 25 |
| Share Capital | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| Reserves & Surplus | 82 | 63 | 60 | 54 | 43 | -3 | -32 | -46 | -50 | -52 |
Ambalal Sarabhai Enterprises Income Statement Screener - Profit & Revenue Analysis
Screen Ambalal Sarabhai Enterprises income statement and profit fundamentals. Analyze AMBALALSA quarterly results. Ambalal Sarabhai Enterprises reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹46 and net profit was ₹4, equal to earnings per unit of ₹0.52, at an operating margin of 10%.
In that period expenses were ₹39, interest cost ₹1 and tax ₹1. The next period listed, 2026-Mar, shows revenue of ₹69 and net profit of ₹7.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 46 | 69 | 55 | 46 | 49 | 66 | 52 | 48 | 43 | 59 | 45 | 43 | 38 | 50 | 38 |
| Expenses | 39 | 60 | 49 | 44 | 39 | 67 | 47 | 42 | 40 | 50 | 41 | 39 | 40 | 41 | 34 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 7 | 9 | 6 | 2 | 10 | 0 | 5 | 5 | 3 | 9 | 4 | 4 | -3 | 9 | 5 |
| Operating Profit % | 10.00% | 9.00% | 6.00% | 1.00% | 4.00% | -3.00% | -2.00% | 6.00% | 1.00% | 9.00% | 6.00% | 3.00% | -11.00% | 8.00% | 4.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 5 | 6 | 4 | 0 | 8 | -2 | 3 | 3 | 1 | 8 | 2 | 2 | -5 | 7 | 4 |
| Tax | 1 | 0 | 1 | 1 | 0 | -2 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 1 | 0 |
| Net Profit | 4 | 7 | 4 | -1 | 8 | 0 | 2 | 3 | 0 | 9 | 1 | 1 | -5 | 6 | 3 |
| EPS | 0.52 | 0.85 | 0.40 | -0.07 | 1.07 | -0.04 | 0.29 | 0.34 | 0.05 | 1.18 | 0.15 | 0.14 | -0.64 | 0.72 | 0.40 |
Ambalal Sarabhai Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen AMBALALSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹13, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹10 and financing activities used ₹2.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 13 | -18 | 9 | 6 | 12 | -2 | -7 | 19 | -7 | 5 |
| Investing Activities | -10 | 13 | -5 | -17 | 5 | 10 | 17 | -9 | 18 | -3 |
Financing and Net Cash | ||||||||||
| Financing Activities | -2 | -2 | -3 | 9 | -19 | -6 | -14 | -6 | -2 | -6 |
| Net Cash Flow | 1 | -6 | 1 | -2 | -3 | 2 | -4 | 4 | 8 | -4 |
Ambalal Sarabhai Enterprises Shareholding Pattern Screener
See Ambalal Sarabhai Enterprises shareholding pattern with promoter, FII, and DII holdings. Check Ambalal Sarabhai Enterprises promoter holding and ownership changes for AMBALALSA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 31.36%, foreign institutions 0.00%, domestic institutions 0.01% and the public 58.90%, spread across 167,066 shareholders.
The shareholder count was 167,066 in 2026-Jun, compared with 167,599 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 31.36% | 31.36% | 31.36% | 31.35% | 31.35% | 31.35% | 31.35% | 31.35% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.34% | 0.34% | 0.38% | 0.38% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.10% | 0.10% | 0.01% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 58.90% | 58.67% | 58.45% | 58.36% | 58.06% | 57.42% | 57.08% | 57.59% |
| Other Holding | 9.74% | 9.96% | 9.85% | 9.95% | 10.20% | 10.75% | 11.47% | 11.06% |
| Shareholder Count | 167,066 | 167,599 | 168,396 | 170,015 | 169,630 | 170,912 | 171,221 | 172,338 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Ambalal Sarabhai Enterprises. Ambalal Sarabhai Enterprises dividend yield can be compared with peers and other stocks in the market.
Ambalal Sarabhai Enterprises Stock Index Membership - Nifty & Sensex
See which indices include Ambalal Sarabhai Enterprises stock. Check AMBALALSA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Ambalal Sarabhai Enterprises Market Events Screener - Corporate Actions
Get Ambalal Sarabhai Enterprises corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Ambalal Sarabhai Enterprises stock events that may affect AMBALALSA share price, along with derivatives, futures and options activity and sector gainers.
14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 12, 2026, with a record date of August 12, 2026.
It is followed by Annual General Meeting dated July 30, 2026 and Quarterly Result Announcement dated May 21, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 8.30% |
| 2026-07-30 | 2026-07-30 | Annual General Meeting | NA | -5.68% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 5.78% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | -3.73% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.59% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -8.25% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | -14.69% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 1.28% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.14% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 5.94% |
| 2024-06-29 | 2024-06-29 | Annual General Meeting | NA | 2.31% |
| 2023-09-28 | 2023-09-28 | Annual General Meeting | NA | 36.67% |
| 2023-09-21 | 2023-09-21 | Extraordinary General Meeting | NA | 24.58% |
| 2022-09-21 | 2022-09-21 | Annual General Meeting | NA | 0.33% |
Ambalal Sarabhai Enterprises Competitors Screener - Peer Stocks Comparison
Screen AMBALALSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Ambalal Sarabhai Enterprises Company Announcements - News & Reports Screener
Screen AMBALALSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 28, 2026.
The next most recent announcements are dated August 14, 2026 and August 13, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-28 | Closure of Trading Window | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Submission Of Quarterly Snapshots | - |
| 2026-08-12 | Results- Financial Results For Quarter Ended 30.06.2026 | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12.08.2026 | - |
| 2026-08-06 | Clarification On Price Movement | - |
| 2026-08-05 | Clarification Sought from Ambalal Sarabhai Enterprises Ltd<BR> | - |
| 2026-08-05 | Plant Visit Updates | - |
| 2026-08-05 | Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidate Financial Results Of The Company For Quarter Ended 30.06.2026 Along With Limited Review Report Of Auditors Thereon | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-08 | Reg. 34 (1) Annual Report. | - |
| 2026-07-07 | Reg. 34 (1) Annual Report. | - |
| 2026-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-29 | Closure of Trading Window | - |
| 2026-05-27 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Shareholders Meeting Intimation | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹46.32, within a 52-week range of ₹30.89 to ₹48.27. The P/E ratio is 22.32 and the P/B ratio is 1.91, with earnings per unit of ₹2.32. Market capitalisation stands at ₹290.36 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.